Download PDF
Thromb Haemost 1991; 65(01): 110
DOI: 10.1055/s-0038-1647464
Letter to the Editor
Schattauer GmbH Stuttgart

Portal Vein Thrombosis Repermeabilization with rt-PA

Sérgio Mies
The Liver Unit (LIM/37), University of São Paulo Medical School, São Paulo, Brazil
,
Fernando Alfieri Jr
The Liver Unit (LIM/37), University of São Paulo Medical School, São Paulo, Brazil
,
Dalton Fischer Chamone
The Liver Unit (LIM/37), University of São Paulo Medical School, São Paulo, Brazil
,
Silvano Raia
The Liver Unit (LIM/37), University of São Paulo Medical School, São Paulo, Brazil
› Author Affiliations
Further Information

Publication History

Received 10 July 1990

Accepted after revision 28 August 1990

Publication Date:
02 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Bergmann SR, Fox K AA, Ter-Pogossian MM, Sobel BE. Clotselective coronary thrombolysis with tissue-type plasminogen activator. Science 1983; 220: 1181-1183
    CrossrefPubMedGoogle Scholar
  • 2 Tiefenbrunn AJ, Robison AK, Kurnik PB, Ludbrook PA, Sobel BE. Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology. Circulation 1985; 71: 110-116
    CrossrefPubMedGoogle Scholar
  • 3 Van de WerfE, Bergmann SR, Fox K AA, De Geest H, Hoyng CE, Sobel BE, Collen D. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. Circulation 1984; 69: 605-610
    CrossrefPubMedGoogle Scholar
  • 4 Jaffe AS, Sobel BE. Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Jama 1986; 255: 237-239
    CrossrefPubMedGoogle Scholar
  • 5 Verstraete M, Bounameaux H, De Cock R, Van De WerfE, Collen D. Pharmocokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) itt humans. J Pharmacol Exp Ther 1985; 235: 506-512
    PubMedGoogle Scholar
  • 6 Angelli G, Buchanan MR, Fernandez E, Van Ryn J, Hirsh J. Sustained thrombolysis with DNA-recombinant tissue-type plasminogen activator in rabbits. Blood 1985; 66: 399-401
    PubMedGoogle Scholar
  • 7 Matsuo O, Rijken DC, Collen D. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinease in vitro. Thromb Haemostas 1981; 45: 225-229
    PubMedGoogle Scholar